Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma
Author:
Affiliation:
1. Department of Urology; UC San Diego Health System; La Jolla CA USA
2. Glickman Urological and Kidney Institute; Cleveland Clinic; Cleveland OH USA
3. Department of Urology; Spectrum Health; Grand Rapids MI USA
Funder
Stephen Weissman Kidney Cancer Research Fund
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13490/fullpdf
Reference29 articles.
1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015
2. Renal cell cancer stage migration;Kane;Cancer,2008
3. Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation;Patil;Cancer,2010
4. Systemic therapy for renal cell carcinoma;Motzer;J Urol,2000
5. Molecular marker for predicting treatment response in advanced renal cell carcinoma: does the promise fulfill clinical need?;Garcia-Roig;Curr Urol Rep,2014
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The use of platelets as a clinical tool in oncology: opportunities and challenges;Cancer Letters;2024-06
2. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry;Clinical Genitourinary Cancer;2022-08
3. Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study;BMC Cancer;2022-06-13
4. Development and validation of nomogram based on a novel platelet index score to predict prognosis in patients with renal cell carcinoma;Journal of Cancer;2021
5. Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients;Frontiers in Cardiovascular Medicine;2018-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3